Pityriasis Lichenoides: PLEVA, PLC, Symptoms, Diagnosis, and Care

Pityriasis lichenoides is an uncommon inflammatory skin eruption that can appear in crops and linger or return over time. It includes two overlapping patterns: the more sudden pityriasis lichenoides et varioliformis acuta (PLEVA) and the slower, often more persistent pityriasis lichenoides chronica (PLC). Spots often appear on the trunk and upper arms or thighs. Some become crusted or ulcerated, while others form small red-brown bumps with a fine scale.

The condition can look like several more common rashes, so a dermatologist may examine the distribution and sometimes take a small skin biopsy. Many cases improve over time, but the course varies. Treatment is tailored to symptoms, extent, age, and the clinician’s findings; evidence for individual treatments is limited. This guide explains the spectrum, what to watch for, how diagnosis is made, and what care may involve.

Pityriasis lichenoides is not usually a medical emergency. A rare severe form can cause fever, widespread painful ulcers, and illness. Seek urgent medical care if a rapidly spreading ulcerative rash occurs with high fever, marked weakness, severe pain, mouth or genital sores, or other systemic symptoms. For a persistent new rash without these features, schedule a routine clinical assessment rather than trying to diagnose it from photographs.

Pityriasis lichenoides at a glance

Pityriasis lichenoides (PL) is a spectrum, not two perfectly separate diseases. PLEVA usually begins more abruptly, with successive crops of small red, purple, or brown papules. Some lesions develop a central blister, dark or bloody crust, or a shallow ulcer. PLC tends to produce many smaller red-brown papules with a delicate scale; older and newer spots may be present at the same time. Some people show a mixture or move from an acute-looking crop to a chronic pattern.

The exact cause is not known. Researchers have considered an unusual immune response after an infection, a reaction to a medication, and other immune-cell processes, but these are hypotheses rather than established causes. A recent illness or medication may be relevant to mention at an appointment, yet a timing link alone does not prove that it caused the rash. Do not stop a prescribed medicine without speaking with its prescriber.

PL most often affects children, adolescents, and young adults, but it can occur at any age and in any skin tone. It is not considered contagious and is not caused by poor hygiene. Itching or burning can occur, and spots may leave temporary lighter or darker marks after they flatten. Ulcerative lesions sometimes leave small scars. The emotional effect of visible or recurrent spots is also part of care.

How PLEVA and PLC can look

Acute pattern: PLEVA

PLEVA often begins over days with multiple small, round or oval bumps, most often on the chest, back, abdomen, upper arms, or thighs. New crops can appear while older spots are healing. The colour may be pink or red on lighter skin and more purple, brown, or subtle on darker skin. In some lesions, the center forms a tiny blister or pustule, then a darker or blood-stained crust. A shallow ulcer can develop, especially in more inflamed spots.

Itch and burning range from absent to bothersome. A person may notice that spots look different from one another because they are at different stages. After a spot settles, the skin may look lighter or darker than the surrounding area for a while. This post-inflammatory colour change is not automatically a permanent scar. Ulcers that extend deeper can heal with small pitted or varioliform marks.

PLEVA may settle over weeks, but timing differs and some cases recur or take longer. The rash can evolve toward a more chronic PLC-like pattern. A photo diary, taken in consistent light with dates, can help show whether new crops are appearing, but it cannot confirm the diagnosis and should not delay an examination if the rash is painful, extensive, or changing quickly.

Chronic pattern: PLC

PLC tends to appear more gradually, often as many small, flat or slightly raised reddish-brown papules with a fine, adherent scale. Dermatology texts sometimes describe the scale as mica-like because it can look thin and shiny. Spots may be scattered across the trunk and proximal limbs. Older spots can fade while new ones appear, so the rash may seem to wax and wane for months or, in some people, longer.

PLC may cause little discomfort, though itch can occur. As the inflammation fades, areas of lighter or darker pigment can remain for a time. Persistent scale or repeated crops can be frustrating even if a person otherwise feels well. A stable chronic rash still deserves diagnosis when it has not been assessed, because psoriasis, pityriasis rosea, medication reactions, and other conditions can resemble PLC.

Why spots change and what the colour means

Individual PL lesions can move through several surface changes as inflammation evolves. A small papule may develop a fine scale; in PLEVA it may form a central blister, pustule, or dark crust and occasionally break down into a shallow ulcer. In PLC, papules more often remain small and scaly. Because new crops can form while older lesions fade, a single examination may show several stages at once.

After inflammation, the skin sometimes produces less or more pigment in the affected area. The resulting light or dark mark may last longer than the active bump and can be more noticeable in deeper skin tones. It does not by itself mean the rash is still active or that a scar has formed. A depression, persistent texture change, or area that is repeatedly ulcerating is different and should be shown to a clinician.

Colour descriptions in medical references often emphasize redness, which may not be easy to see on every skin tone. On brown or dark skin, lesions can look violet, grey-brown, deep brown, or primarily lighter than surrounding skin. Good lighting and examination of texture, scale, shape, and distribution are useful. A clinician should avoid relying on redness alone when evaluating the rash.

There is no single home sign that distinguishes PL from other eruptions. Try not to scrape scale or squeeze a papule to see what is underneath; this can cause bleeding, infection, or additional pigment changes. Gentle washing, a plain fragrance-free moisturizer if the skin is dry, and avoiding new irritating products can reduce avoidable irritation while awaiting assessment.

Possible causes and what is known

The cause of pityriasis lichenoides remains uncertain. One theory is that it reflects an immune response to an infection, but no single germ explains most cases. Another possibility is an inflammatory reaction to a medication in some people. Because these links are not settled, clinicians treat a recent infection or medication change as context to review, not proof of the cause.

When discussing timing, include prescription medicines, over-the-counter products, supplements, recent vaccinations, and illnesses. The clinician may decide that a medication review or targeted testing is useful, particularly if the presentation is severe or unusual. Do not delay vaccination or stop medicine based on an online list of reported associations; decisions should be made with the clinician who knows your history.

PL is not generally spread by touch, shared clothing, towels, or swimming pools. Household members do not need to isolate from a person with the rash. A clinician may investigate infection when symptoms or history support it, but that is different from saying that the rash itself is contagious. Reassurance about transmission can be helpful for families when new spots appear.

It is also not caused by dirt or poor skin care. Over-washing, harsh scrubs, or disinfectants do not treat the immune inflammation and can injure already irritated skin. Gentle skin care can support comfort, but it does not replace diagnosis or prescribed treatment if the eruption is extensive or persistent.

When to seek medical care

Arrange a routine appointment with a dermatologist or primary-care clinician if you have a new widespread crop of papules, a scaly eruption that keeps returning, spots that do not heal as expected, or uncertainty about whether a rash is PL. A dermatologist can assess the shape and distribution, look for signs that suggest a mimic, and decide whether a biopsy or other test would be useful.

Seek same-day urgent medical advice if numerous lesions become painful ulcers, especially when the change is rapid or accompanied by fever, severe fatigue, swollen glands, joint pain, mouth or genital sores, abdominal symptoms, breathing symptoms, or feeling seriously unwell. A rare severe ulceronecrotic form can affect more than the skin and needs specialist care. If there is severe illness, trouble breathing, confusion, or inability to drink, use emergency services.

Also contact a clinician promptly for warmth, spreading redness, pus, increasing pain, or fever around broken skin, which can suggest a secondary infection. Do not assume that every crusted spot is infected, and do not start leftover antibiotics. A clinician can decide whether infection is present and whether treatment is needed.

For children, urgent evaluation is appropriate when a rapidly spreading rash is paired with fever, marked lethargy, painful mouth sores, or difficulty drinking. For a well child with stable spots, a non-emergency appointment is usually reasonable. If a child’s behavior or hydration changes, trust that change and call for medical advice.

How clinicians diagnose pityriasis lichenoides

Diagnosis starts with the story and a full skin examination. The clinician may ask when the first spots appeared, whether they arrived in crops, whether older ones crusted or ulcerated, how itchy or painful they are, and whether there was a recent infection or medication change. They may examine the trunk, limbs, scalp, mouth, nails, and other involved areas depending on symptoms.

Sometimes the pattern is characteristic enough for a clinician to make a working diagnosis. Because PL can resemble other conditions, a small punch biopsy is often considered when the diagnosis is uncertain, the rash is persistent or atypical, lesions are ulcerated, or the clinician needs to exclude another condition. The sample is examined under a microscope. The result is interpreted together with the clinical pattern; pathology alone may not answer every question.

Potential look-alikes include guttate psoriasis, pityriasis rosea, lichen planus, viral eruptions such as chickenpox, arthropod-bite reactions, medication eruptions, and lymphomatoid papulosis. A few other disorders, including cutaneous T-cell lymphoma, can overlap in appearance or biopsy findings in selected cases. This list is not a reason to assume a serious disease; it explains why clinicians may use follow-up or biopsy when the picture is unclear.

Blood tests or infection testing are not automatically needed for every patient. A clinician may order specific tests when symptoms, exposure history, immune status, or a severe presentation make them relevant. Ask what question a proposed test is meant to answer and how the result would affect the plan. If a biopsy is performed, ask how to care for the site and when to expect results.

Course and outlook

Many cases improve spontaneously, but there is no reliable timetable for an individual person. PLEVA may settle over weeks, while PLC often lasts for months and can relapse for a longer period. The two patterns can overlap, and an eruption can change over time. A slow course does not mean the condition is dangerous, but it can require patience and a practical plan for itch, visible marks, and follow-up.

Temporary pigment changes may outlast the bumps. These often gradually become less noticeable, although the time varies and some pigment change can persist. Deeper ulcers can leave small scars. Sun exposure can make contrast more visible in some people, so sunscreen and clothing on exposed areas may help protect healing skin from additional discoloration. Do not use bleaching creams or strong acids on inflamed or broken skin without medical advice.

A diagnosis of PL is not the same as a diagnosis of skin cancer. Rare reports describe overlap with or later recognition of other lymphoproliferative conditions, which is one reason a clinician may biopsy atypical or persistent lesions and arrange follow-up if the pattern changes. The existence of rare reports should not be used to predict that this will happen to an individual patient.

If spots repeatedly return, keep the planned review rather than assuming that every new crop is identical to the last. A new symptom, ulceration, unusual pain, or a change in overall health may warrant re-examination. A dated photo record can help the care team compare changes, especially when the rash fluctuates between appointments.

Treatment options and realistic expectations

No treatment has been proven to cure every case, and the rash may improve on its own. If lesions are mild, the clinician may recommend observation, a simple comfort plan, and follow-up. If itch or inflammation is troublesome, a clinician may consider a topical treatment for symptom relief. The choice depends on age, lesion location, severity, biopsy findings when available, and other health conditions.

Narrowband UVB phototherapy is commonly considered for more widespread or persistent disease, particularly PLC. It is delivered in a clinic or supervised setting with a planned course and dose adjustments. Do not try to reproduce medical phototherapy with a tanning bed or deliberate sun exposure: those sources are not controlled treatment and add skin-cancer risk. Ask how many visits may be needed, what side effects are possible, and how response will be assessed.

Oral medicines such as certain antibiotics may be prescribed for their anti-inflammatory effect in selected cases, not because PL is necessarily a bacterial infection. The evidence comes mainly from small studies and case series, so benefits are uncertain and must be weighed against side effects, allergies, interactions, pregnancy considerations, and antimicrobial stewardship. A prescription should come from a clinician after considering the full history.

For severe or treatment-resistant disease, a dermatologist may discuss other prescription anti-inflammatory or immune-modulating options. These require careful monitoring and are not appropriate for every patient. Do not borrow another person’s medication or use leftover tablets. Ask what outcome is expected, how long a trial will last, what monitoring is needed, and what the next step would be if the rash does not respond.

Published treatment studies are limited and difficult to compare because PL can resolve naturally, patients differ, and follow-up is often short. This makes shared decision-making important. For some people, the safest choice is to wait and monitor; for others, discomfort, widespread lesions, ulceration, or quality-of-life effects justify active treatment. Revisit the plan if its burden outweighs its benefit.

Comfortable skin care while the rash heals

Use lukewarm water and a mild, fragrance-free cleanser. Pat rather than rub the skin dry. A plain moisturizer can reduce dryness and friction if it does not sting. Choose loose, breathable clothing over affected areas when possible, and avoid adhesive bandages on widespread lesions unless a clinician recommends a dressing for an individual ulcer.

Try not to scratch, pick crusts, or shave directly over active lesions. Keeping nails short and using a cool compress may reduce the urge to scratch. If an area breaks open, follow the clinician’s wound-care instructions; do not apply alcohol, hydrogen peroxide, essential oils, or strong antiseptics routinely, as they can irritate tissue and slow comfortable healing.

People with a rash on sun-exposed skin can use clothing and a broad-spectrum sunscreen on intact skin as tolerated. Some lesions may be more visible after tanning or sun exposure. Do not use tanning as a treatment. If a prescribed phototherapy plan is being used, follow the clinic’s guidance about outdoor sun exposure and protective eyewear.

Keep a brief symptom log if the rash fluctuates. Record new crops, itch, burning, pain, ulceration, fever, recent illnesses, medication changes, treatment use, and any missed appointments. This can help a clinician distinguish a stable chronic pattern from a meaningful change without needing daily photographs or constant checking.

Visible rashes can affect sleep, confidence, work, school, and social activity. If the condition is affecting mood or daily life, mention it at the visit. The treatment conversation can include comfort and quality of life, not only how many spots are present. A child may benefit from simple explanations that the rash is not contagious and is not their fault.

Questions to ask at a dermatology visit

• Which features of my rash fit PLEVA, PLC, or another condition?
• Would a biopsy clarify the diagnosis or change the treatment plan?
• What should I watch for that would mean I need earlier review?
• Is any medication or recent illness relevant, and should I keep taking my medicines?
• What treatment goal are we aiming for: less itch, fewer new spots, faster healing, or another outcome?
• How will we know whether treatment is working, and when should we reconsider it?
• Could this plan affect school, work, pregnancy, other conditions, or current medicines?

Bring a current medication list, including supplements and topical products. If a biopsy was performed elsewhere, ask for the pathology report to be shared with the treating clinician. If you have photos, choose a few dated examples that show the change over time rather than a large unorganized collection.

Ask for clear instructions in writing if treatment requires a schedule, monitoring, or follow-up. Confirm who to contact for a worsening rash and how quickly you should expect a response. A practical plan gives you a way to act if the course changes without needing to interpret every spot alone.

Frequently asked questions

Sources and further reading

• DermNet: Pityriasis lichenoides — clinical forms, appearance, diagnosis, complications, treatment, and outlook.
• British Association of Dermatologists Patient Hub: Pityriasis lichenoides — patient information on course, treatment, and self-care.
• Merck Manual Professional: Pityriasis lichenoides — subtype features, clinical diagnosis, biopsy, and treatment options.
• Bellinato et al. A systematic review of treatments for pityriasis lichenoides. Journal of the European Academy of Dermatology and Venereology. 2019 — summarizes available treatment studies and their limitations.
• Geller et al. Pityriasis Lichenoides in Childhood: Review of Clinical Presentation and Treatment Options. Pediatric Dermatology. 2015 — review focused on children.

Medical disclaimer: This article is for general education and is not a substitute for individualized diagnosis or treatment. A persistent or changing rash should be assessed by a qualified clinician. Seek urgent advice for a rapidly spreading painful ulcerative rash with fever or other systemic symptoms.